OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit


Ahmed Lasfar

Ahmed Lasfar

New Jersey Medical School, USA

Department of Pharmacology and Toxicology.


Dr. Ahmed Lasfar is a Researcher working on improving the use of Interferon in cancer and determining the mechanisms of resistance to interferon therapy at the University Hospital Cancer Center New Jersey Medical School/University of Medicine and Dentistry of New Jersey. He is a member of the Department of Biochemistry and Molecular Biology at NJMS/UMDNJ. He has completed his Post Doctoral training 1999-2002 in the Department of Molecular Genetics Microbiology and Immunology at Robert Wood Johnson Medical School UMDNJ under the supervision of Dr. Sidney Pestka Leader for the approval of IFN use in Clinic by the FDA in 1986 and the winner of the National Medal of Technology in 2002. Dr. Ahmed lasfar has received a PhD in Immunology from Paris University of Science France in 1996. He has completed his Master Degree in Rene Descartes University School of Medicine France 1992. He received several awards including two excellence scientific awards from the New Jersey Commission on Cancer Research and one award from the International Society for Interferon and Cytokine Research.


Interferon lambda signaling in normal and cancer cells
Strategies for the improvement of interferon treatment in melanoma
Role of Interferon lambdas in Hepatocelluar Carcinoma
Mechanisms of TGF beta resistance